Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjie Deng

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nanotechnology|January 18, 2024
Synthesizing high performance LNMO cathode materials with porous structure by manipulating reynolds number in a microreactorTongli Liu, Hongjie Deng, Fa He, et al.
Dermatology and Therapy|March 4, 2021
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot StudyUlrich Mrowietz, A David Burden, Andreas Pinter, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 17, 2019
ErratumDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitorIan McCaffery, Yanyan Tudor, Hongjie Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumorsPeter J Rosen, Christopher J Sweeney, Dorothy J Park, et al.
Frontiers in Human Neuroscience|September 18, 2015
Alteration of Basal Ganglia and Right Frontoparietal Network in Early Drug-Naïve Parkinson's Disease during Heat Pain Stimuli and Resting StateYing Tan, Juan Tan, Jiayan Deng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumorsWilliam D Tap, George Demetri, Phillip Barnette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1Anthony W Tolcher, John Sarantopoulos, Amita Patnaik, et al.
Oncotarget|July 10, 2015
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumorsDavid S Hong, Peter Rosen, A Craig Lockhart, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nanotechnology|January 18, 2024
Synthesizing high performance LNMO cathode materials with porous structure by manipulating reynolds number in a microreactorTongli Liu, Hongjie Deng, Fa He, et al.
Dermatology and Therapy|March 4, 2021
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot StudyUlrich Mrowietz, A David Burden, Andreas Pinter, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 17, 2019
ErratumDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitorIan McCaffery, Yanyan Tudor, Hongjie Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumorsPeter J Rosen, Christopher J Sweeney, Dorothy J Park, et al.
Frontiers in Human Neuroscience|September 18, 2015
Alteration of Basal Ganglia and Right Frontoparietal Network in Early Drug-Naïve Parkinson's Disease during Heat Pain Stimuli and Resting StateYing Tan, Juan Tan, Jiayan Deng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumorsWilliam D Tap, George Demetri, Phillip Barnette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1Anthony W Tolcher, John Sarantopoulos, Amita Patnaik, et al.
Oncotarget|July 10, 2015
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumorsDavid S Hong, Peter Rosen, A Craig Lockhart, et al.
Pageof 3